A review of complaints for the architect free psa, lot# 13217fn00 assay determined that there are no trends for the product related to patient results.Return testing was not completed as returns were not available.Global data was evaluated and the patient median result for lot 13217fn00 was analyzed and found to be within established baselines and confirms no systemic issues for this lot.A review of the manufacturing documentation did not identify any issues associated with the customer¿s observation.It is noted that the date of patient testing was may2021 and the reagent lot that was used, 13217fn00, expired on 26feb2021.Per product labeling, the reagent kits should be only used until the expiration date.A review of the product labeling concluded that the issue is sufficiently addressed.Based on the investigation no systemic issue or product deficiency was identified for the architect free psa, lot# 13217fn00 assay.
|